Sierra Leone celebrates end of Ebola epidemic

Will A New Ebola Vaccine Eradicate Ebola In West Africa?



FREETOWN, Nov 7 (Reuters) - Residents of Sierra Leone's capital held a candlelit vigil and celebrations overnight to mark the end of an Ebola epidemic that has killed almost 4,000 people including more than 200 health workers since it began last year.

Following 42 days with no new cases, the West African nation's epidemic will be declared officially over on Saturday at a ceremony attended by President Ernest Bai Koroma and U.N. World Health Organization (WHO) representative Anders Nordstrom.

Thousands of people gathered under the Cotton Tree, a massive tree in the centre of the capital, Freetown, overnight for a candlelight vigil organised by women's groups to pay tribute to health workers who died.

For more on this story, scroll through the gallery below:

8 PHOTOS
Ebola vaccine in Guinea
See Gallery
Sierra Leone celebrates end of Ebola epidemic
A health worker prepares a vaccination on March 10, 2015 at a health center in Conakry during the first clinical trials of the VSV-EBOV vaccine against the Ebola virus. The World Health Organization (WHO) said on March 5 that clinical trials launched on March 7 in Guinea marked the last step before the vaccine is available on the market. AFP PHOTO / CELLOU BINANI (Photo credit should read CELLOU BINANI/AFP/Getty Images)
A woman gets vaccinated on March 10, 2015 at a health center in Conakry during the first clinical trials of the VSV-EBOV vaccine against the Ebola virus. The World Health Organization (WHO) said on March 5 that clinical trials launched on March 7 in Guinea marked the last step before the vaccine is available on the market. AFP PHOTO / CELLOU BINANI (Photo credit should read CELLOU BINANI/AFP/Getty Images)
A woman gets vaccinated on March 10, 2015 at a health center in Conakry during the first clinical trials of the VSV-EBOV vaccine against the Ebola virus. The World Health Organization (WHO) said on March 5 that clinical trials launched on March 7 in Guinea marked the last step before the vaccine is available on the market. AFP PHOTO / CELLOU BINANI (Photo credit should read CELLOU BINANI/AFP/Getty Images)
A man gets vaccinated on March 10, 2015 at a health center in Conakry during the first clinical trials of the VSV-EBOV vaccine against the Ebola virus. The World Health Organization (WHO) said on March 5 that clinical trials launched on March 7 in Guinea marked the last step before the vaccine is available on the market. AFP PHOTO / CELLOU BINANI (Photo credit should read CELLOU BINANI/AFP/Getty Images)
A dose of the VSV-EBOV vaccine against the Ebola virus sits on March 10, 2015 at a health center in Conakry during its first clinical trial on humans. The World Health Organization (WHO) said on March 5 that clinical trials launched on March 7 in Guinea marked the last step before the vaccine is available on the market. AFP PHOTO / CELLOU BINANI (Photo credit should read CELLOU BINANI/AFP/Getty Images)
A woman gets vaccinated on March 10, 2015 at a health center in Conakry during the first clinical trials of the VSV-EBOV vaccine against the Ebola virus. The World Health Organization (WHO) said on March 5 that clinical trials launched on March 7 in Guinea marked the last step before the vaccine is available on the market. AFP PHOTO / CELLOU BINANI (Photo credit should read CELLOU BINANI/AFP/Getty Images)
A man gets vaccinated on March 10, 2015 at a health center in Conakry during the first clinical trials of the VSV-EBOV vaccine against the Ebola virus. The World Health Organization (WHO) said on March 5 that clinical trials launched on March 7 in Guinea marked the last step before the vaccine is available on the market. AFP PHOTO / CELLOU BINANI (Photo credit should read CELLOU BINANI/AFP/Getty Images)
HIDE CAPTION
SHOW CAPTION
of
SEE ALL
BACK TO SLIDE

"They died so we could live," Fatmata, a university student, said with tears in her eyes. Many of the health workers who died were infected due to inadequate protective equipment and training.

The country's first confirmed Ebola survivor, Victoria Yillia, told the crowd she was "happy that this disease which almost killed me has finally ended". She appealed to authorities not to forget survivors, many of whom have faced social stigma and persistent health problems.

Elsewhere in the city, residents celebrated the end of the epidemic, which forced schools to close, overwhelmed healthcare systems and hurt the local economy.

"We're happy. I feel free again after a period of bondage in the hands of Ebola," said trader Joseph Katta as he clutched a pint of beer at a pub in the suburb of Lumley.

Ebola has killed more than 11,300 people in Sierra Leone, Liberia and Guinea since the epidemic was announced in March 2014 and about 28,500 were infected, according to WHO data. Sierra Leone's death toll was 3,955 people.

Liberia was declared free of Ebola on Sept. 3, while a handful of cases remain in Guinea.

The 42-day countdown to be declared Ebola-free starts when the last patient tests negative a second time, normally after a 48-hour gap following their first negative test.

Fear of the virus transformed the three countries and hampered efforts in Sierra Leone and Liberia to recover from civil wars.

At the height of the epidemic, the two countries ordered everyone to stay indoors for days at a time in an attempt to identify new cases and slow the disease's spread.

More from AOL.com:
With attacks on Clinton, Democratic race enters new phase
The Rewind: The top news and buzzy stories from the week of November 2
78-foot tree hoisted into place at Rockefeller Center

Read Full Story

Sign up for Breaking News by AOL to get the latest breaking news alerts and updates delivered straight to your inbox.

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.